Carboxylesterase 2 is downregulated in colorectal cancer following progression of the disease. [electronic resource]
Producer: 20080320Description: 178-81 p. digitalISSN:- 1532-4192
- Adenocarcinoma -- drug therapy
- Animals
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Biomarkers, Tumor -- metabolism
- Blotting, Western
- Camptothecin -- analogs & derivatives
- Carboxylesterase -- metabolism
- Colorectal Neoplasms -- drug therapy
- Disease Progression
- Down-Regulation
- Humans
- Immunoglobulin G -- immunology
- Irinotecan
- Mice
- Neoplasm Staging
- Topoisomerase I Inhibitors
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.